how can model informed drug development impact your program?
Published 10 months ago • 804 plays • Length 43:49Download video MP4
Download video MP3
Similar videos
-
3:13
value focused midd: oncology model-informed drug development program
-
4:05
value focused midd: respiratory syncytial virus (rsv) model-informed drug development program
-
20:21
model informed drug development approaches for immunogenicity assessments workshop
-
3:16
value focused midd: influenza model-informed drug development program
-
15:51
model informed drug development approaches for immunogenicity assessments workshop
-
36:24
physiologically-based pharmacokinetics modeling: an approach for designing better clinical trials
-
55:39
a best practice framework for applying pbpk modeling to pediatric drug development
-
57:36
project optimus & pediatric drug development
-
54:03
mastering formulation excellence with simcyp biopharmaceutics: exclusive webinar recording
-
52:43
overview of drug discovery & development process
-
39:17
an introduction to pbpk, simcyp discovery, and the simcyp product suite
-
33:21
using model based meta analysis to inform drug development for auto immune diseases
-
11:17
modeling and simulation to support pediatric drug development
-
1:05:56
leveraging modeling and simulation for neonatal and infant drug development
-
31:10
model informed drug development approaches for immunogenicity assessments workshop
-
17:03
model informed drug development approaches for immunogenicity assessments workshop
-
10:17
certara - improving investment in drug development through biosimulation
-
22:57
modeling informed drug development
-
2:18
the model-informed drug discovery and development program
-
17:32
model informed drug development approaches for immunogenicity assessments workshop
-
1:01:14
pbpk modeling & simulation to support asciminib nda submission and inform drug product label
-
1:00:21
optimize drug development with public data and predictive models – model-based meta-analysis (mbma)